Boosting virtual screening with machine learning allowed for a 10-fold time reduction in the processing of 1.56 billion drug-like molecules. Researchers from the University of Eastern Finland teamed up with industry and supercomputers to carry out one of the world’s largest virtual drug screens.
Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition
Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models.